Omnicare $350 million revolving facility priced at Libor plus 325 bps

By Sara Rosenberg

New York, May 5 - Omnicare Inc.'s $350 million five-year revolving credit facility is priced at Libor plus 325 basis points with a 50 bps unused fee, according to a market source.

The deal was launched in late April, at which time price talk was revealed as Libor plus 225 bps to 350 bps based on leverage.

SunTrust, JPMorgan, Barclays and Citigroup are the bookrunners on the deal, with SunTrust the left lead.

Proceeds will be used for general corporate purposes.

Senior leverage is around 1.43 times and total leverage is around 3.64 times.

Omnicare is a Covington, Ky.-based pharmaceutical services company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.